🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Effects of Finerenone on Readmissions for Heart Failure: Insights from FINEARTS-HF In over >1000 patients randomized during or shortly after hospitalization, finerenone appeared to favorably influence risk of early HF readmissions. #HeartFailure2025

Intriguing new data out in JACC Journals in time for #HeartFailure2025 from ATTRibuteCM Stabilization of TTR (prealbumin) leads to immediate & sustained rise in TTR levels Degree of rise identifies those likely to derive mortality protection from TTR stabilizers #MedIQHF2025

Excellent study linking acoramidis, TTR levels, & mortality in ATTRIBUTE-CM now in JACC Journals Congrats Jessica Regan on leading our accompanying editorial (bit.ly/436F0i0) & 🙏 outstanding collaborators Michelle Kittleson MD PhD Michel Khouri Frederick L Ruberg Duke Heart

📌The Kidney is a window for the Heart Chronic kidney disease share risk factors, patological pathways & high mortality with CV disease (#heartfailure) BUT also new therapies that improve the outcomes: SGLT2i + Finerenone + GLP1a Shelley Zieroth #HeartFailure2025

♻️ 💔Recovered EF ≠ recovered risk Finerenone delivers—LVEF history doesn’t change that 🔹 HFimpEF = 5% of trial pop, median EF rise: +12% 🔸 CV event rates still high (21.4 vs 16.0 per 100 pt-yrs) 🔹 Finerenone benefit consistent: RR 0.72 in HFimpEF 🔸 Greater absolute risk

Finerenone in Heart Failure with Improved Ejection Fraction in #FINEARTSHF led by Maria A. Pabón, MD in JAMA Cardiology jamanetwork.com/journals/jamac…

Great week at St Boniface Hospital. The Cardiac Sciences Manitoba structural team randomized 🇨🇦's 1st pt into the EMPOWER trial! RCT of Carillon Mitral Contour System. 🙏 u to Prof Peter Nordbeck (Germany) +Kristy Kimball from Cardiac Dimensions Great team of Malek Kass AshishShah

1 week left to save the most on your registration to #ESCCongress 2025 with #WCCardio 🌍 Be part of cardiology’s most anticipated experience. ⏰ Register by 31 May to benefit from the early fee ✈️ Explore negotiated travel & hotel rates 📍 Madrid, 29 August – 1 September

🧵 Can a diabetes drug reverse hypertrophic cardiomyopathy? A rigorous new study says yes—empagliflozin rewires heart metabolism and improves function in a mouse model of HCM. #CardioTwitter #HeartFailure #Metabolism #SGLT2i 🧬🫀👇 💡 Background: HCM is driven by sarcomeric

Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote HFPEF new stem cell signature of cardiometabolic HFpEF and support a role for myeloid maladaptive fatty acid metabolism in the promotion of systemic inflammation ahajournals.org/doi/abs/10.116…

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis efficacy and safety of finerenone in patients with CKD and T2D was not modified by baseline diuretic use onlinelibrary.wiley.com/doi/abs/10.100…

Don’t you wish you could use #AI to 🤔 🫀deliver better care to pts? 🫀educate trainees more effectively? 🫀be more productive!?!?! I do!!! Join us as we learn from experts in these domains tomorrow night!!! Don’t miss it! #AHAWIC AHA Science

Efficacy of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy and Mild Symptoms: SEQUIOA-HCM Trial Patients with oHCM and mild symptoms treated with aficamten achieved significant improvement across range of clinically relevant outcomes academic.oup.com/eurheartj/adva…

#Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other #CVDs BiykemBozkurt onlinelibrary.wiley.com/doi/10.1002/ej… Henry Han Amr Abdin Giuseppe Galati #EJHF

I’ve spoken with Premier Wab Kinew and offered Canada’s full support as his province battles wildfires around Flin Flon.    The premier and I are in close contact, and the federal government stands ready to assist Manitoba’s provincial wildfire teams. cbc.ca/news/canada/ma…

Kidney Dysfunction in Heart Failure: Core Curriculum 2025 Suboptimal decongestion, diuretic resistance, low use rates of guideline-directed medical therapy in individuals with kidney dysfunction and HF contribute to poor CV and kidney outcomes sciencedirect.com/science/articl…

Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by Immunonephrology Working Group (IWG) of ERA new therapeutic agents and strategies shifting from solely reduction of proteinuria to preservation of GFR and attenuation of decline academic.oup.com/ndt/article/40…

Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Assessment of an Old Problem The burden of mutually maladaptive and comorbid AF and HFrEF is growing. The benefits of AF rhythm control are greatest among patients with HFrEF. jacc.org/doi/10.1016/j.…

Only a few hours left! The iCARDIO #CVD in Obesity Guidelines Public Review closes today. Your voice matters, help improve global strategies for CVD prevention & treatment in obesity. Submit feedback now: icardioalliance.org #Obesity #Cardiology #PublicReview #HeartHealth

🔥 Clinical & financial implications of inpatient & outpatient management of #WorseningHF 🏥 Hospitalization 🚨 ER discharge 💉 Outpatient IV diuretics Associated with ⬆️ ☠️ ⬇️ QoL ⬆️ Costs #HFUA 🍀 🔥 EJHF Editor-in-Chief Gregg Fonarow MD Andrew J Sauer MD Michele Emdin bit.ly/43mBbFw